Crossref
TCT-292 Clinically Significant Residual Shunt After Patent Foramen Ovale Closure: Does Device Design Matter?
JACC · 2026-11 · 88 (18) · B126
DOI: 10.1016/j.jacc.2026.09.385 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-11. Verfasst von Teiji Akagi und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Akagi, T., Nakashima, M., Morikawa, T., Takaya, Y., & Hirohata, A. (2026). TCT-292 Clinically Significant Residual Shunt After Patent Foramen Ovale Closure: Does Device Design Matter?. JACC, 88(18), B126. https://doi.org/10.1016/j.jacc.2026.09.385
Vancouver
Akagi T, Nakashima M, Morikawa T, Takaya Y, Hirohata A. TCT-292 Clinically Significant Residual Shunt After Patent Foramen Ovale Closure: Does Device Design Matter?. JACC. 2026;88(18):B126. doi:10.1016/j.jacc.2026.09.385
BibTeX
@article{Akagi2026,
author = {Akagi, Teiji and Nakashima, Mitsutaka and Morikawa, Takao and Takaya, Yoichi and Hirohata, Atsushi},
title = {TCT-292 Clinically Significant Residual Shunt After Patent Foramen Ovale Closure: Does Device Design Matter?},
journal = {JACC},
year = {2026},
volume = {88},
number = {18},
pages = {B126},
doi = {10.1016/j.jacc.2026.09.385}
}
EUVIMED